Fallopian Tube Endometrioid Adenocarcinoma

• CLINICAL_TRIALS trial_result · 2024-10-24
  Clinical Trial Update: Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]

  Clinical trial update reporting results from a Phase 1/2 study of ruxolitinib phosphate in combination with paclitaxel and carboplatin for S…

• CLINICAL_TRIALS trial_result · 2024-06-18
  Clinical Trial Update: Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents [Phase 2]

  Phase 2 study comparing standard of care versus a triplet targeted immunotherapy combination in Fallopian tube mucinous adenocarcinoma and o…

• CLINICAL_TRIALS trial_result · 2022-06-10
  Clinical Trial Update: First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]

  A Phase 2 trial evaluating first-line bevacizumab, carboplatin, and paclitaxel in stage III-IV ovarian, primary peritoneal, and fallopian tu…

• CLINICAL_TRIALS trial_result · 2020-11-06
  Clinical Trial Update: Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

  Phase 2 clinical trial evaluating pembrolizumab, bevacizumab, and cyclophosphamide in recurrent ovarian, fallopian tube, or primary peritone…

• CLINICAL_TRIALS trial_result · 2019-09-17
  Clinical Trial Update: Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]

  Phase 2 trial evaluating elesclomol sodium with paclitaxel in patients with recurrent or persistent ovarian epithelial cancer, fallopian tub…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.